Zymeworks (ZYME) Receivables (2022 - 2026)

Zymeworks (ZYME) has 5 years of Receivables data on file, last reported at $4.7 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables fell 81.0% year-over-year to $4.7 million; the trailing twelve-month figure through Mar 2026 stood at $4.7 million (down 81.0% YoY), and the FY2025 full-year result was $4.6 million, down 91.69% from the prior year.
• Receivables improved to $4.7 million in Q1 2026, from $4.6 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $67.3 million in Q3 2023 to a low of $2.6 million in Q2 2025.
• A 5-year average of $30.1 million and a median of $29.4 million in 2025 frame the typical range for Receivables.
• Across the five-year window, Receivables soared 899.9% in 2023 and slumped 91.8% in 2025, its largest moves.
• Tracing ZYME's Receivables over 5 years: stood at $33.4 million in 2022, then sank by 41.69% to $19.5 million in 2023, then surged by 186.57% to $55.8 million in 2024, then sank by 91.69% to $4.6 million in 2025, then increased by 0.78% to $4.7 million in 2026.
• Business Quant data shows ZYME's Receivables at $4.7 million in Q1 2026, $4.6 million in Q4 2025, and $29.4 million in Q3 2025.